Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;105(4):717-725.
doi: 10.1016/j.jhin.2020.05.037. Epub 2020 Jun 1.

Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence

H Harding  1 , A Broom  2 , J Broom  3
Affiliations
Review

Aerosol-generating procedures and infective risk to healthcare workers from SARS-CoV-2: the limits of the evidence

H Harding et al. J Hosp Infect. 2020 Aug.

Abstract

The transmission behaviour of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still being defined. It is likely that it is transmitted predominantly by droplets and direct contact and it is possible that there is at least opportunistic airborne transmission. In order to protect healthcare staff adequately it is necessary that we establish whether aerosol-generating procedures (AGPs) increase the risk of transmission of SARS-CoV-2. Where we do not have evidence relating to SARS-CoV-2, guidelines for safely conducting these procedures should consider the risk of transmitting related pathogens. Currently there is very little evidence detailing the transmission of SARS-CoV-2 associated with any specific procedures. Regarding AGPs and respiratory pathogens in general, there is still a large knowledge gap that will leave clinicians unsure of the risk to themselves when offering these procedures. This review aimed to summarize the evidence (and gaps in evidence) around AGPs and SARS-CoV-2.

Keywords: Aerosol-generating procedures; Infectivity; Nosocomial infection; SARS-CoV-2; Transmission.

PubMed Disclaimer

Comment in

References

    1. World Health Organization WHO Director-General’s opening remarks at the media briefing on COVID-19. 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re... Available at: [last accessed March 2020]
    1. Lake M.A. What we know so far: COVID-19 current clinical knowledge and research. Clin Med. 2020;20:124–127. doi: 10.7861/clinmed.2019-coron. - DOI - PMC - PubMed
    1. Wang J., Du G. COVID-19 may transmit through aerosol. Irish J Med Sci. 2020 Mar 24:1–2. doi: 10.1007/s11845-020-02218-2. - DOI - PMC - PubMed
    1. Judson S.D., Munster V.J. Nosocomial transmission of emerging viruses via aerosol-generating medical procedures. Viruses. 2019;11:940. doi: 10.3390/v11100940. - DOI - PMC - PubMed
    1. Seto W.H., Conly J.M., Pessoa Silva C.L., Malik M., Eremin S. Infection prevention and control measures for acute respiratory infections in healthcare settings: an update. Eastern Medit Health J. 2013;19:S39–S47. doi: 10.26719/2013.19.supp1.S39. - DOI - PubMed